Publication | Closed Access

From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

Medicinal ChemistryAnti-inflammatorySelective Cox-2 InhibitorBiochemistryMedicineNatural SciencesPharmacological AgentIndolalkanoic AcidsPharmacotherapySelective Cyclooxygenase-2 InhibitorsAnti-cancer AgentPharmacologyPharmaceutical ChemistryDrug Discovery